Replies to post #532 on BioNovo, Inc. (fka BNVIQ)

[softballdaddy]

I only have a starter here ... will be adding as I sell other positions...the PR issued after hours also gave some data on the menopause testing as far as dosages etc.

Bionovo Announces First Quarter 2011 Highlights and Financial Results
Now - PR Newswire
Bionovo, Inc. (NASDAQ: BNVI) today announced first quarter highlights and financial results for the three months ended March 31, 2011. "We started the first quarter by raising the necessary capital to advance Menerba, our lead drug for the treatment of menopausal hot flashes," said Isaac Cohen, O.M.D., Bionovo's Chairman and Chief Executive Officer. "We have since been proceeding with our clinical plan and manufacturing Menerba for the various clinical and non-clinical studies. As previously stated, we expect to be able to initiate the Phase 3 clinical trials for Menerba in the 3rd quarter of this year."